Gerald J. Dal Pan,
MD

Dr. Dal Pan currently serves as the Director of the Office of Surveillance and Epidemiology in the Food and Drug Administration’s Center for Drug Evaluation and Research, where he has been responsible since 2005 for the Center’s programs in adverse event surveillance and analysis, pharmacoepidemiology, risk management, and medication error prevention. In this capacity, he is involved in both the premarket and postmarket regulation of drugs and therapeutic biologics, and in the implementation of the drug safety provisions of the Food and Drug Administration Amendments Act and other initiatives. He is a member of the World Health Organization Advisory Committee on the Safety of Medicinal Products, and has served on working groups of the Council of International Organization of Medical Sciences and the International Conference on Harmonisation.

Dr. Dal Pan completed residency training in Internal Medicine at the Hospital of the University of Pennsylvania and in Neurology at the Johns Hopkins Hospital. He is board certified in both Internal Medicine and Neurology. He joined the Food and Drug Administration in 2000 as a medical reviewer in the Center’s Office of New Drugs. Before working at the Food and Drug Administration, he was a faculty member in the Department of Neurology at Johns Hopkins and also worked in the pharmaceutical industry. Dr. Dal Pan received his MD at Columbia University College of Physicians and Surgeons, and his Master of Health Science in Clinical Epidemiology at the Johns Hopkins University School of Hygiene and Public Health.